Scienze e tecniche psicologiche a.a.2010-2011 Lingua inglese Translation practice Text 1 Introduction 1. Introduction In 1914 the German paediatrician Albert Niemann described a Jewish child with damage to the brain and nervous system. Subsequently in 1927 Ludwig Pick analyzed the tissues from deceased children and provided evidence of a new storage disease, not previously described. Currently, the term ‘NiemannPick Disease’ (NPD) refers to a group of genetic diseases of the metabolism, characterized by lipid storage and autosomal recessive inheritance. In 1914 the German paediatrician Albert Niemann described a Jewish child with damage to the brain and nervous system. Subsequently in 1927 Ludwig Pick analyzed the tissues from deceased children and provided evidence of a new storage disease, not previously described. Currently, the term ‘Niemann-Pick Disease’ (NPD) refers to a group of genetic diseases of the metabolism, characterized by lipid storage and autosomal recessive inheritance. Thematic progression 1 Introduction In 1914 …. Subsequently in 1927 …. Currently, ….. Thematic progression 2 In 1914 the German paediatrician Albert Niemann described … Subsequently in 1927 Ludwig Pick analyzed … and provided …. Currently, the term ‘Niemann-Pick Disease’ (NPD) refers to … 1. Introduction In 1914 the German paediatrician Albert Niemann described a Jewish child with damage to the brain and nervous system. Subsequently in 1927 Ludwig Pick analyzed the tissues from deceased children and provided evidence of a new storage disease, not previously described. Currently, the term ‘Niemann-Pick Disease’ (NPD) refers to a group of genetic diseases of the metabolism, characterized by lipid storage and autosomal recessive inheritance. Definitions of terms in English Recessive: (genetics) relating to or denoting heritable characteristics controlled by genes which are expressed in offspring only when inherited from both parents (transl. recessivo) Autosome (biology): any chromosome that is not a sex chromosome (traduzione autosomo. agg. autosomico) Translation proposal In 1914 the German paediatrician Albert Niemann described a Jewish child with damage to the brain and nervous system. Subsequently in 1927 Ludwig Pick analyzed the tissues from deceased children and provided evidence of a new storage disease, not previously described. Nel 1914 il pediatra tedesco Albert Niemann descrisse un bambino ebreo con danni al cervello e al sistema nervoso. Successivamente nel 1927, Ludwig Pick studiò i tessuti di alcuni bambini deceduti e fornì delle prove di una nuova tesaurismosi*, diversa da quelli fino ad allora descritte. *Tesaurismosi. Accumulo progressivo di sostanze metaboliche normali o abnormi nelle cellule e nei tessuti, senza che sia possibile da parte degli stessi o dell'organismo utilizzarle o eliminarle. Translation proposal Currently, the term ‘Niemann-Pick Disease’ (NPD) refers to a group of genetic diseases of the metabolism, characterized by lipid storage and autosomal recessive inheritance. Oggi con la dizione ‘Malattia di Niemann-Pick (MNP) è indicato un gruppo di patologie genetiche del metabolismo, caratterizzate da tesaurismosi lipido e da eredità autosomica recessiva. \ Alan Crocker, in 1958, was the first to propose a classification of this series of metabolic disorders, based on biochemical and clinical features. Translation proposal Alan Crocker, in 1958, was the first to propose a classification of this series of metabolic disorders, based on biochemical and clinical features. Fu Alan Crocker, nel 1958 il primo a proporre una classificazione di questa serie di disturbi metabolici sulla base degli aspetti biochimici e clinici. Types A and B of Niemann-Pick disease (NPD-A and NPDB) are due to a lack of acid sphingomyelinase (A-SMase) activity, a lysosomal enzyme encoded by the SMPD1 gene (sphingomyelin phosphodiesterase 1) located on chromosome 11. The enzyme defect results in a pathological accumulation of sphingomyelin (SM) and other lipids, particularly within the tissues of the reticulo-endothelial system (RES) – including the spleen, lymph nodes, bone marrow, thymus and mononuclear phagocytes – which along with the liver and lungs, is deeply affected by the disease. Niemann-Pick disease type C (NPD-C) is a chronic neuropathy, with clinical, biochemical and molecular features distinct from those of NPD-A and –B (primary sphingolipidosis). Common symptoms are hepatosplenomegaly and neurodegeneration, resulting in progressive motor dysfunction, cognitive decay and psychicdisorders. NPD-C is divided into 3 subgroups according to the age of clinical onset and the respective phenotype: childhood presentation, late-childhood presentation and adolescent and adult presentation. (253 words) Types A and B of Niemann-Pick disease (NPD-A and NPD-B) are due to a lack of acid sphingomyelinase (A-SMase) activity, a lysosomal enzyme encoded by the SMPD1 gene (sphingomyelin phosphodiesterase 1) located on chromosome 11. The enzyme defect results in a pathological accumulation of sphingomyelin (SM) and other lipids, particularly within the tissues of the reticulo-endothelial system (RES) – including the spleen, lymph nodes, bone marrow, thymus and mononuclear phagocytes – which along with the liver and lungs, is deeply affected by the disease. Translation proposal Types A and B of Niemann-Pick disease (NPD-A and NPD-B) are due to a lack of acid sphingomyelinase (A-SMase) activity, a lysosomal enzyme encoded by the SMPD1 gene (sphingomyelin phosphodiesterase 1) located on chromosome 11. I tipi A e B della malattia Niemann-Pick (MNP-A e MNP-B) sono dovuti ad un deficit di attività di sfingomielinasi acida (A-SMasi), un enzima lisosomiale codificato dal gene SMPD1 localizzato sul cromosoma 11. Translation proposal The enzyme defect results in a pathological accumulation of sphingomyelin (SM) and other lipids, particularly within the tissues of the reticulo-endothelial system (RES) – including the spleen, lymph nodes, bone marrow, thymus and mononuclear phagocytes – which along with the liver and lungs, is deeply affected by the disease. Il difetto enzimatico determina un accumulo patologico di sfingomielina (SM) e di altri lipidi, in particolare all’interno delle cellule del sistema reticolo-endoteliale (RES), il quale comprende milza, linfonodi, midollo osseo, timo e fagociti mononucleati, e che, insieme a fegato e polmoni, risulta maggiormente colpito dalla malattia. Niemann-Pick disease type C (NPD-C) is a chronic neuropathy, with clinical, biochemical and molecular features distinct from those of NPD-A and –B (primary sphingolipidosis). Common symptoms are hepatosplenomegaly and neurodegeneration, resulting in progressive motor dysfunction, cognitive decay and psychic disorders. NPD-C is divided into 3 subgroups according to the age of clinical onset and the respective phenotype: childhood presentation, late-childhood presentation and adolescent and adult presentation. Translation proposal Niemann-Pick disease type C (NPD-C) is a chronic neuropathy, with clinical, biochemical and molecular features distinct from those of NPD-A and –B (primary sphingolipidosis). La malattia di Niemann-Pick di tipo C (MNPC) è una forma neuropatica cronica ed è distinta dal punto di vista clinico, biochimico e molecolare dai tipi A e B (sfingolipidosi primitive). Translation proposal Common symptoms are hepatosplenomegaly and neurodegeneration, resulting in progressive motor dysfunction, cognitive decay and psychic disorders. I sintomi principali sono l’epatosplenomegalia e la neurodegenerazione che comporta disfunzioni motorie progressive, decadimento cognitivo, disturbi psichiatrici. Translation proposal NPD-C is divided into 3 subgroups according to the age of clinical onset and the respective phenotype: childhood presentation, late-childhood presentation and adolescent and adult presentation. La MNP-C è suddivisa in 3 sottogruppi clinici secondo l’età d’insorgenza clinica e il relativo fenotipo:insorgenza infantile, insorgenza della tarda infanzia, e insorgenza dell’adolescenza e dell’ età adulta. Nominal groups Niemann-Pick disease type C (NPD-C) clinical, biochemical and molecular features progressive motor dysfunction, cognitive decay psychic disorders. childhood presentation, late-childhood presentation adolescent and adult presentation.